Start-Up Stadium Featured Live Pitches from these
2022 Finalists (Winners to be announced in August):
Full Schedule in Presentation Order Below:
(Use the Filter Function Here to Search Your Way with Session Type set to "Start-Up Stadium")
Start-Up Stadium Presentations took place in the
Sails Pavilion, Upper Level, San Diego Convention Center
This year's Start-Up Stadium included two special sessions of presentations:
California Life Sciences WIB-FAST Program for life sciences companies founded or co-founded by women, Tuesday, June 14, 2:00-4:00 pm PT
SPARK at Stanford Program for academic technology transfer entrepreneurs, Wednesday, June 15, 2:00-4:00 pm PT
Start-Up Stadium was designed to provide start-up companies with the opportunity to access key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology event.
This year will also feature separate evaluation of the seed-stage finalists' presentations with the highest-scoring seed company being eligible for a prize courtesy of The Innovation Space.
SEED-STAGE FINALIST PRIZE FROM THE INNOVATION SPACE:
Fast-track admission in the Fall 2022 or Spring 2023 cohort of The Innovation Space’s Science Inc. virtual accelerator program and/or spotlight position in The Innovation Space’s monthly Spark Factory virtual event. Moreover, company will also be considered for up to a $200k First Fund investment (residency in The Innovation Space required for First Fund investments)
EMERGING COMPANY FINALIST PRIZE FROM ILLUMINA ACCELERATOR:
Illumina Accelerator will provide the Emerging Company winner of the 2022 Start-Up Stadium program with a "fast-track" accelerator application with guaranteed interview, a nomination into the final selection phase for a $10,000 sequencing grant, and a one-hour coaching session.
Thank You to our 2022 Start-Up Stadium Sponsors and Supporters
Start-Up Stadium Sponsor
Start-Up Stadium Sponsor
CLS WIB-Fast Community Supporter
Presenting Finalists for Start-Up Stadium benefit from exposure to investors, discounted registration fees, and access to BIO One-on-One Partnering™.
What Kind of Exposure do Applicants Receive?
The goal of Start-up Stadium is to increase start-ups’ engagement and visibility with investors, state and regional affiliates, and early-stage companies at the beginning of their life-cycle. All applications were reviewed by judges experienced in evaluation of start-ups' growth potential as companies. During the BIO International Convention, investor judges will attend live start-up presentations and engage in Q&A/feedback with start-up finalists.
BIO 2022 attendees enjoyed this exciting opportunity to meet the finalists and hear their pitches during sessions on June 14, 15, and 16.
Who can participate? Companies that have...
- Raised less than $10M since inception
- Previous business pitch or competition experience
- Fewer than 20 full-time employees
- Not previously been named a BIO Start-Up Stadium winner
Have additional questions? Download the Start-Up Stadium Pitch Guide Instructions here.
BIO Thanks the 2022 Start-Up Stadium Judges:
Orrin Ailloni-Charas, MD, MBA, Managing Partner, Cura Capital
Christopher Aleong, Chief Business Officer, Lumosa Therapeutics
John Behr, Partner, SV Health Investors
James Buxton, Senior Associate, NEA
Joseph Charalel, Senior Associate, Pivotal bioVenture Partners (US)
David H. Crean, Managing General Partner, Cardiff Advisory LLC
Bettina Ernst, Director, BERNINA BioInvest
David Fox, Co-founder, Modality.ai
Yinghong Gao, Venture Partner, Viva BioInnovator
Juliet Gomez, Program Manager, Flinn Foundation
Gábor Gyülvészi, Sr. Associate, Nextech Invest AG
Lu Han, Partner, Lumira Ventures
Daniel Jacobs, Managing Director, Pathway Bioventures
Scott M. Kahn, PhD, Founder, Alykomed Global Solutions LLC
Vince Kohli, Global Tech Impact Capitalist, Trillion Ventures Global Capital Fund
Benjamin Li, Senior Associate, Pivotal bioVenture Partners (US)
David Malek, Venture Partner, Pivotal bioVenture Partners (US)
Marc Martin-Casas, Head of Illumina Accelerator, San Francisco, Illumina Accelerator
Laurie K. McNamara, PhD, Esq., Associate, Wilson Sonsini Goodrich & Rosati
Miguel A. Mendez, Managing Director, Facultas Partners
Mariana Mihalusova, Vice President, Venrock
Sandra Miller, General Partner, Cura Capital
Graham Mills, Investment Manager, Abingworth LLP
Ivan Morace, Senior Investment Analyst, MediVentures GmbH
Anton Neschadim, Senior Advisor, GreenSky Capital
Younes Ouahid, Partner, Facultas Partners
William D. Provine, PhD, President & CEO, Innovation Space
Marcie Reilly, Program Manager, Partnerships & Special Projects, Innovation Space
Catello Somma, Associate, TVM Capital Life Science Management GmbH
Lesley Stolz, PhD, VP, Early Innovation Partnering, Johnson & Johnson Innovation
Nilay Thakar, Principal, ARCH Venture Partners
Anton Xavier, Director, Early Stage Life Science Banking, SVB
Kitty Wu, VP, Head of Business Development and Strategy, Fosun Pharma USA
Samuel Wu, Venture Partner, 7G BioVentures
Xiangbin Xu, CEO, QLD Biotherapeutics Inc
Wenping Zhou, Investment Associate, CT innovations
John Zhu, Founder and President, Mayewell Capital